FDA urges DOH to Proceed Using AstraZeneca


Recently, Maria Rosario Vergeire, the Department of Health’s Undersecretary, officially announced 24,823 reported cases under the adverse events following immunization.

Aside from Sinovac, AstraZeneca is the current choice and available in the Philippines. Like Sinovac, people who were injected with the AstraZeneca vaccines, as documented to have had experience reactions.

The total number tallied is 17,503 did have minor AZ vaccine reactions. And another 206 had severe events, which sums up 17,709 affected with adverse effects from AstraZeneca jabs.

News worldwide affirms that there are investigations ongoing about the AstraZeneca vaccines possibly causing the rare blood clot disease to the inoculated.

In truth, the UK and other countries already took precautions to discontinue the use of AstraZeneca as advised by their health experts.

But the Food and Drug Administration in the Philippines urges the Department of Health to proceed with the vaccine’s usage.

From an interview on DZMM, Food and Drug Administration’s Director-General Eric Domingo stated:

“Dito sa atin wala pang nakita ang Adverse Events Committee natin na similar cases, pero sa Europa, at saka sa ibang parte ng mundo, nakita naman na very rare ito na nangyayari.”

(Here (in the Philippines), the Adverse Events Committee have not yet seen any cases similar to those reported (overseas), but in Europe and other parts of the world, it appears that the occurrence (of the disease) is very rare.)”

The Food and Drug Administration gives DOH the signal to vaccinate people with the AstraZeneca COVID-19 vaccine for 59-years-old and younger.

As per the advice of the World Health Organization, the benefits outweigh the risks.

Like it? Share with your friends!